1-3 of 3
Yvonne Tromp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study

Michele Cavo, Sujith Dhanasiri, Valerio De Stefano, Angel Ramírez Payer, Martin Wiesholzer, Yvonne Tromp, Meegahage Ratnakanthi Perera, Valentine Richez-Olivier, Maciej Gil, David Bernasconi, Barbara Gamberi
Journal: Blood
Blood (2022) 140 (Supplement 1): 7195–7196.
https://doi.org/10.1182/blood-2022-162493
Published: 2022
Journal Articles

Safety Profile for Lenalidomide-Based and Non-Lenalidomide-Based First-Line Therapy for Multiple Myeloma in Transplant Ineligible Patients: Real-World Evidence from a European Post-Authorization Safety Study

Michele Cavo, Valerio De Stefano, MD, Angel Ramirez Payer, Martin Wiesholzer, Yvonne Tromp, Gaëtan Vanstraelen, Baerbel Schaedlich, Richez Valentine, Sujith Dhanasiri, Elisabeth Kueenburg, Barbara Rosettani, Claire Martin, Stefano Pozzi, Pamela Bacon, Barbara Gamberi
Journal: Blood
Blood (2019) 134 (Supplement_1): 5580.
https://doi.org/10.1182/blood-2019-124555
Published: 2019
Journal Articles

Combined Treatment of Bortezomib, Continuous Low-Dose Cyclophosphamide and Dexamethasone Followed By One Year of Maintenance Treatment for Refractory or Relapsed Multiple Myeloma Patients: A Prospective Phase II Study

Esther GM Waal de, MD, Linda Munck de, Gerhard Woolthuis, MD, Annet velden Van Der, MD, Yvonne Tromp, MD, Mels Hoogendoorn, MD PhD, Edo Vellenga, MD PhD, Sjoerd Hovenga, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4733.
https://doi.org/10.1182/blood.V124.21.4733.4733
Published: 2014